Cibinqo Tablet, Film Coated
Product Images NDC 0069-0435

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Cibinqo (NDC 0069-0435). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cibinqo 01)

FDA Label Image

Logo (Cibinqo 02)

Logo (Cibinqo 02)
This is a product label for Pfizer medications that are distributed by Pfizer Labs, a division of Pfizer Inc. located in New York, NY 10017.*
FDA Label Image

Logo (Cibinqo 03)

Logo (Cibinqo 03)
This is a label from Pfizer Labs, a division of Pfizer Inc. located in New York City with a zip code of 10017.*
FDA Label Image

Principal Display Panel (50 mg Tablet Bottle Label)

Principal Display Panel (50 mg Tablet Bottle Label)
This text contains information on the storage conditions of tablets containing 50 mg citinib, produced and distributed by Pfizer Inc., New York. The recommended temperature for storage is between 20°C to 25°C (68°F to 77°F), with excursions permitted between 5°C to 30°C (59°F to 86°F). It also includes a warning not to crush, split, or chew the tablets and a reference to a medication guide that should always be dispensed with the tablets.*
FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Principal Display Panel (100 mg Tablet Bottle Label)
This is a medication guide for Pfizer's ibrutinib tablets. The recommended storing temperature is between 20°C - 25°C (68°F - 77°F) with no more than mild temperature excursions between 5°C - 30°C (59°F - 86°F) permitted. The pack should not be removed and the medication use and dosage instructions can be found in the accompanying prescribing information. Each tablet contains 100mg of the drug. The tablets should not be crushed, split, or chewed. It is distributed by Pfizer Labs, a division of Pfizer Inc, New York. This product is for prescription only in Ireland.*
FDA Label Image

Principal Display Panel (200 mg Tablet Bottle Label)

Principal Display Panel (200 mg Tablet Bottle Label)
This is a description of a medication called Cibinqo in tablet form with a strength of 200mg. The ideal temperature of storage is between 20°C to 25°C, with permissible excursions between 5°C to 30°C. The medication is not to be crushed, split, or chewed, and requires a prescription. The text also contains an NDC code (0069-0435-30) and a GTIN number. The rest of the text is illegible or irrelevant.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.